prevalence and incidence of multiple sclerosis in tehran, iran

Authors

sharareh eskandarieh

pouria heydarpour

seyedeh-robab elhami

mohammad ali sahraian

abstract

background: tehran is the capital of iran with an increasing multiple sclerosis (ms) incidence. a retrospective population-based study was conducted to evaluate the status of ms prevalence and ms incidence trends in tehran province, iran. methods: a population-based study was conducted from 1991 to 2014 in tehran province, the capital city of iran based on iranian ms society (imss) registry system. a structured questionnaire design to cover the important epidemiological variables, related at the individual level for ms. a monte carlo permutation method was utilized to test whether the apparent change in ms trends during 1991-2014 was statistically significant. results: ms incidence was significantly increased during our study period. the annual percent change (apc) was 12.8% in women during 1991 to 2004 and 12.5% in men during the same period. the point prevalence of ms was 101.39 per 100000 populations in 2014. the age-adjusted prevalence rates were 134.03 and for male patients were 42.45 per 100000. conclusion: ms prevalence and incidence in tehran are markedly rising, it is crucial to elucidate the causes of the increasing trends and implement efficient policies lowering disease burden.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran

BACKGROUND Tehran is the capital of Iran with an increasing Multiple Sclerosis (MS) incidence. A retrospective population-based study was conducted to evaluate the status of MS prevalence and MS incidence trends in Tehran Province, Iran. METHODS A population-based study was conducted from 1991 to 2014 in Tehran Province, the capital city of Iran based on Iranian MS Society (IMSS) registry sys...

full text

Prevalence and Incidence of Multiple Sclerosis (MS) in Guilan Province

Introduction: The aim of this study was to investigate the prevalence and incidence of multiple sclerosis (MS) in Guilan Province) and to compare the standardized prevalence by the factor of age in this province. Methods: The study was a cross-sectional design that was conducted in 2018 at the Guilan MS Society (GMSS) on people with multiple sclerosis and examined the 654 people with multiple ...

full text

Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran

Background: Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system, which is accompanied by significant disabilities. Although there are some published data regarding the epidemiological features of MS in other parts of Iran, scarce data are available about the prevalence and demographic characteristics of MS in Fars province. The current study...

full text

The Time-trend of Multiple Sclerosis Incidence and Prevalence in Khuzestan Province, Iran

Background: The prevalence and incidence of Multiple Sclerosis (MS) have increased in Iran. Objectives: This study aimed to observe the temporal trends and provide a predictive model in the prevalence and incidence of MS in Khuzestan Province, Iran. Materials & Methods: This cross-sectional study was performed from 2006 to 2019 in Khuzestan Province, Southwestern Iran, on 2676 patients regi...

full text

Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran

BACKGROUND Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system, which is accompanied by significant disabilities. Although there are some published data regarding the epidemiological features of MS in other parts of Iran, scarce data are available about the prevalence and demographic characteristics of MS in Fars province. The current study ...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of public health

جلد ۴۶، شماره ۵، صفحات ۶۹۹-۷۰۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023